AI ultrasound
The partnership aims to increase health practitioners' capabilities to master 10 essential cardiac views.
The company's FDA-cleared autonomous ultrasound imaging system uses a probe to allow for imaging in resource-limited environments to support trauma medicine.
The organizations will codevelop algorithms to help healthcare professionals analyze point-of-care ultrasound images for cardiac care.
Sonio will remain an independent company following the acquisition.
The companies' joint offering, ThinkSono Guidance, attained Class IIb CE mark approval in March with upcoming plans for FDA approval.
The funds will be used to speed up global adoption of AI algorithms on Philips Lumify Handheld Ultrasound to help rural providers identify abnormalities during pregnancy.
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
Its technology helps eliminate manual steps in reporting and interpretation of ultrasound images of breast and thyroid.